Skip to main content

Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.

Publication ,  Journal Article
Gao, C-L; Rawal, SK; Sun, L; Ali, A; Connelly, RR; Bañez, LL; Sesterhenn, IA; McLeod, DG; Moul, JW; Srivastava, S
Published in: Clin Cancer Res
July 2003

PURPOSE: Prostate-specific antigen (PSA) test has become a widely used screening test in prostate cancer (CaP). However, low specificity of serum PSA leads to many false-positive and false-negative results and clinical uncertainty. Development of CaP-specific diagnostic and prognostic markers is needed. Detection of circulating PSA-expressing cells (CPECs) in blood and bone marrow of CaP patients has potential in molecular diagnosis and prognosis. Our novel observations of the frequent presence of CPECs in CaP patients with organ-confined disease by reverse transcription (RT)-PCR-PSA assay in epithelial cells enriched from peripheral blood (ERT-PCR/PSA) have led us to test the hypothesis that CPECs have diagnostic potential for CaP. EXPERIMENTAL DESIGN: Epithelial cells from peripheral blood of radical prostatectomy patients or prostate biopsy patients were isolated using antiepithelial cell antibody, Ber-EP4-coated magnetic beads, and total RNA specimens from these cells were analyzed for PSA expression by RT-PCR. RESULTS: Peripheral blood specimens of 108 of 135 (80.0%) CaP patients were positive in ERT-PCR/PSA assay. Peripheral blood specimens from 45 control men were virtually negative (97.8%). In the blinded investigation, 84 patients who had biopsy for suspicion of CaP were evaluated by ERT-PCR/PSA assay. Eighteen of 22 (81.8%) patients with biopsy-proven CaP were positive, and 54 of 62 (87.1%) patients with biopsy negative for CaP were negative in this assay (P < 0.001). CONCLUSIONS: Our study provides intriguing novel results showing that the majority of patients with clinically organ-confined CaP contain CPECs. Strong concordance between the biopsy results and ERT-PCR/PSA assay (sensitivity 81.8%; specificity 87.1%) suggests a potentially new diagnostic application of this type of assay in CaP diagnosis.

Duke Scholars

Published In

Clin Cancer Res

ISSN

1078-0432

Publication Date

July 2003

Volume

9

Issue

7

Start / End Page

2545 / 2550

Location

United States

Related Subject Headings

  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Polymerase Chain Reaction
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Magnetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gao, C.-L., Rawal, S. K., Sun, L., Ali, A., Connelly, R. R., Bañez, L. L., … Srivastava, S. (2003). Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients. Clin Cancer Res, 9(7), 2545–2550.
Gao, Chun-Ling, Sudhir K. Rawal, Leon Sun, Amina Ali, Roger R. Connelly, Lionel L. Bañez, Isabell A. Sesterhenn, David G. McLeod, Judd W. Moul, and Shiv Srivastava. “Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.Clin Cancer Res 9, no. 7 (July 2003): 2545–50.
Gao C-L, Rawal SK, Sun L, Ali A, Connelly RR, Bañez LL, et al. Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients. Clin Cancer Res. 2003 Jul;9(7):2545–50.
Gao, Chun-Ling, et al. “Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.Clin Cancer Res, vol. 9, no. 7, July 2003, pp. 2545–50.
Gao C-L, Rawal SK, Sun L, Ali A, Connelly RR, Bañez LL, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients. Clin Cancer Res. 2003 Jul;9(7):2545–2550.

Published In

Clin Cancer Res

ISSN

1078-0432

Publication Date

July 2003

Volume

9

Issue

7

Start / End Page

2545 / 2550

Location

United States

Related Subject Headings

  • Reverse Transcriptase Polymerase Chain Reaction
  • RNA
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Prognosis
  • Polymerase Chain Reaction
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Magnetics